ClinicalTrials.Veeva

Menu

Simplified Insulin Regimen for the Elderly

University of Miami logo

University of Miami

Status and phase

Terminated
Phase 4

Conditions

Type 2 Diabetes Mellitus

Treatments

Drug: Insulin Aspart
Drug: Insulin Lispro
Drug: Insulin Glargine

Study type

Interventional

Funder types

Other

Identifiers

NCT03660553
20180541

Details and patient eligibility

About

Basal-bolus insulin therapy, which includes one injection of long acting insulin and three injections of short acting insulin is the most commonly used insulin treatment. However, many older patients find the basal-bolus insulin regimen hard to manage because it involves 4 injections and 4 blood glucose tests each day. It is possible that a simplified treatment that involves one injection of long acting insulin daily and two blood glucose tests daily might be equally effective. This simplified regimen, if effective, would be easier to use and might result in less errors. Therefore, the investigators want to conduct this study to compare using a single daily injection of basal insulin with the usual basal-bolus insulin regimen in elderly patients (age >65 years) with type 2 diabetes.

Enrollment

7 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-Age >65 years

Exclusion criteria

  • Unable to provide informed consent
  • Enrollment in another research study
  • History of hypoglycemia unawareness
  • Pregnant women
  • Prisoners

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

7 participants in 2 patient groups

Multiple Subcutaneous Injection (MSI)
Active Comparator group
Description:
MSI group will receive four insulin injections per day that will include a long acting and a short acting insulin. Short acting insulin will be either insulin aspart or insulin lispro.
Treatment:
Drug: Insulin Lispro
Drug: Insulin Aspart
Drug: Insulin Glargine
Drug: Insulin Glargine
Basal Insulin (BI)
Experimental group
Description:
BI group will receive only one injection of insulin glargine in the morning.
Treatment:
Drug: Insulin Glargine
Drug: Insulin Glargine

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems